EUPRAXIA PHARMACEUTICALS INC. - Common Shares (EPRX)

CUSIP: 29842P105

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Shares
Shares outstanding
53,310,033
Total 13F shares
1,826,270
Share change
+15,689
Total reported value
$5,634,759
Price per share
$3.17
Number of holders
9
Value change
+$50,501
Number of buys
3
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 29842P105?
CUSIP 29842P105 identifies EPRX - EUPRAXIA PHARMACEUTICALS INC. - Common Shares in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of EUPRAXIA PHARMACEUTICALS INC. - Common Shares (EPRX) as of Q4 2024

As of 31 Dec 2024, EUPRAXIA PHARMACEUTICALS INC. - Common Shares (EPRX) was held by 9 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,826,270 shares. The largest 9 holders included SCOTIA CAPITAL INC., Royal Bank of Canada, BANK OF MONTREAL /CAN/, GOLDMAN SACHS GROUP INC, UBS Group AG, RAYMOND JAMES FINANCIAL INC, 180 WEALTH ADVISORS, LLC, MILLENNIUM MANAGEMENT LLC, and NATIONAL BANK OF CANADA /FI/. This page lists 9 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.